• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRIUM MEDICAL CORPORATION ADVANTA V12 COVERED STENT; STENT, RENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRIUM MEDICAL CORPORATION ADVANTA V12 COVERED STENT; STENT, RENAL Back to Search Results
Device Problem Leak/Splash (1354)
Patient Problems Inflammation (1932); Ischemia (1942); Blood Loss (2597)
Event Type  Injury  
Manufacturer Narrative
We are unable to fully investigate this report as no product number, lot number or sample was provided.It is not known what relationship the advanta v12 has to the reported adverse events.The study concluded fb-evar was feasible for post-dissection thoracoabdominal aneurysm.Despite the associated peri-operative risk and high probability of planned or unplanned reintervention, the procedure led to favorable aortic remodeling with false lumen thrombosis and aneurysm regression.Based on the information available atrium has determined that the events described are not related to a product failure.Not available for return.
 
Event Description
Received an article titled fenestrated or branched endovascular aortic repair for post-dissection thoracoabdominal aortic aneurysm.Purpose: fenestrated or branched endovascular aortic repair (fb-evar) usually represents the last stage in endovascular treatment of post-dissection aneurysm after thoracic endograft coverage of entry tear and false lumen embolization.Method: between january 2014 and december 2017, consecutive patients who underwent fb-evar for treatment of post-dissection thoracoabdominal aneurysm (taaa) in one center were included and retrospectively reviewed.Per the article adverse events included: type iii endoleak, spinal cord ischemia, systemic inflammatory response syndrome, respiratory failure, acute kidney injury, bleeding complications and wound complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANTA V12 COVERED STENT
Type of Device
STENT, RENAL
Manufacturer (Section D)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack NH 03054
Manufacturer (Section G)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack NH 03054
Manufacturer Contact
40 continental blvd
merrimack, NH 03054
MDR Report Key8841976
MDR Text Key152675056
Report Number3011175548-2019-00817
Device Sequence Number1
Product Code NIN
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 07/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/30/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/22/2019
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ZENITH FENESTRATED ENDOGRAFT SYSTEM - COOK
Patient Outcome(s) Required Intervention;
-
-